Skip to main content

Table 1 Baseline patient’s characteristics

From: Bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: a meta-analysis

 

Abellas et al. 2017

Azzalini et al. 2016

Fam et al. 2017

Goktekin et al. 2015

Kugler et al. 2017

Lesiak et al. 2016

Mitomo et al. 2016

Ojeda et al. 2015

Ozel et al. 2016

Saad et al. 2016

Vaquerizo et al. 2016

Wiebe et al. 2015

Yamac et al. 2017

Age (years)

59.2 ± 8.7

60.0 ± 9.3

59.40 ± 8.96

56.9 ± 9.4

60.5 ± 7.8

59.9 ± 8.3

60.8 ± 11.0

58 ± 9

61.9 ± 9.7

65.3 ± 10.9

61 ± 10

60.4 ± 9.0

57.8 ± 9.6

Male (%)

89.5

89.5

90.0

85.7

77.5

89.2

98

85.4

75

80

81.8

86.7

Hypertension (%)

44.4

65.4

69.5

78.6

64.3

80

67.8

57

80.5

78.6

91.3

80

Diabetes (%)

22.2

34.0

33.3

21.4

14.3

30

40

33

51.2

26.3

20

34.8

3.3

Smoking (%)

77.8

24.8

48.6

35.7

57.1

35

8

34.1

41.5

47.8

40

Family History (%)

29.6

21.9

32.9

30.8

33.3

Hyperlipidemia (%)

100

69.9

72.4

52.9

71.4

61.5

64

46.3

50.4

65.2

56.7

Prior CABG (%)

2.6

2.9

10

0

5

6.2

17.1

2.7

6.7

Prior PCI (%)

43.8

46.7

17.1

45

53.8

36

56.1

39.3

13.3

Prior stroke/TIA (%)

0

2.6

0

30.8

0

CKD (%)

5.5

2

7.1

15

40.1

0

0

LVEF (%)

53.2 ± 10.1

51.7 ± 6.7

50.7 ± 10.2

57.7 ± 10.8

54 ± 8

59.8 ± 13.8

55.7 ± 15.5

50.2 ± 6.4